CPET differs from standard stress testing in that the workload 'ramps up,' ie, increases gradually and continuously
TABLE 1
Selected cardiopulmonary exercise testing variables Peak Vo 2 Highest oxygen uptake obtained (aerobic capacity) Values vary widely with age, sex, activity level, weight, and disease (< 20 mL/kg/min in elderly; > 90 in elite athletes) Nonspecific but starting point for interpretation and stratification Peak Vo 2 ≥ 85% of predicted is generally favorable; ≤ 14 mL/kg/min carries a poor prognosis in heart failure (≤ 10 if on beta-blockers)
Ventilatory threshold Point at which anaerobic metabolism increases Vo 2 at ventilatory threshold typically is 40%-60% of peak Vo 2 A low value is consistent with deconditioning or disease; a high value is consistent with athletic training Heart rate reserve (Maximum heart rate -resting heart rate) divided by (predicted maximum heart rate -resting heart rate) Reflects chronotropic competence Normal ≥ 80% if not on beta-blocker; ≥ 62% if on betablocker; less than this = chronotropic incompetence Heart rate recovery Maximum heart rate minus rate at 1 minute recovery Recovery ≥ 12 bpm is normal; < 12 is abnormal across all populations; < 6 is threshold in heart failure scoring system LECLERC work for smooth data collection, and graphical display for optimal test interpretation. After undergoing baseline screening spirometry, the patient rides a stationary bicycle or walks on a treadmill while breathing through a nonrebreathing mask and wearing electrocardiographic leads, a blood pressure cuff, and a pulse oximeter. The test starts out easy and gets progressively harder until the patient fatigues, reaches his or her predicted peak Vo 2 , or, as in any stress test, experiences any other clinical indication for stopping, such as arrhythmias, hypotension, or symptoms (rare). We advise patients to wear comfortable workout clothes, and we ask them to try as hard as they can. The test takes about 10 to 15 minutes. Patients are instructed to take all of their usual medications, including beta-blockers, unless advised otherwise at the discretion of the supervising physician. Table 1 lists common CPET variables; Table  2 lists common patterns of results and what they suggest. Other reviews further discuss disease-specific CPET patterns.
What the numbers mean
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Peak Vo 2 . As the level of work increases, the body needs more oxygen, and oxygen consumption (Vo 2 ) increases in a linear fashion up to a peak value (Figure 1 ). Peak Vo 2 is the central variable in CPET. Whereas elite athletes have high peak Vo 2 values, patients with exercise impairment from any cause have lower values, and average adults typically have results in the middle. Peak Vo 2 can be expressed in absolute terms as liters of oxygen per minute, in indexed terms as milliliters of oxygen per kilogram of body weight per minute, and as a percentage of the predicted value.
Ventilatory threshold. Before people reach their peak Vo 2 , they reach a point where the work demand on the muscles exceeds the oxygen that is being delivered to them, and their metabolism becomes more anaerobic. This point is called the anaerobic threshold, or more precisely the ventila- Gas analysis data augment information gathered from conventional stress tests tory threshold. In states of deconditioning or disease, this threshold is often lower than predicted. It can be detected either directly by measuring blood lactate levels or, more often, indirectly from the Vo 2 , Vco 2 , and Ve data (Figure 2) . Ve/Vco 2 slope. As exercise impairment advances, ventilatory efficiency worsens. Put simply, the demands of exercise result in greater ventilatory effort at any given level of work. This is a consequence of ventilationperfusion mismatching from a milieu of metabolic, ventilatory, and cardiac dysregulation that accompanies advanced cardiopulmonary or metabolic disease. 6, 7 The most validated CPET variable reflecting this is the minute ventilation-carbon dioxide relationship (Ve/ Vco 2 slope) (Figure 3) .
Coupled with other common CPET variables and measures such as screening spirometry, electrocardiography, heart and respiratory rate responses, pulse oximetry, and blood pressure, the Ve/Vco 2 allows for a detailed and integrated assessment of exercise performance.
■ USING CPET TO EVALUATE EXERTIONAL DYSPNEA Shortness of breath, particularly with exertion, is a common reason patients are referred to internists, pulmonologists, and cardiologists. It is a nonspecific symptom for which a precise cause can be elusive. Possible causes range from physical deconditioning due to obesity to new or progressive cardiopulmonary or muscular disease.
If conventional initial studies such as standard exercise testing, echocardiography, or spirometry do not definitively identify the problem, CPET can help guide additional investigation or management. Any abnormal patterns seen, together with the patient's clinical context and other test results, can give direction to additional evaluation. Table 2 outlines various CPET patterns that can suggest clinically significant cardiac, pulmonary, or muscle disorders. [8] [9] [10] [11] [12] [13] Alternatively, normal responses reassure the patient and clinician, since they suggest the patient does not have clinically significant disease.
Case 1: Obesity and dyspnea
You evaluate a 53-year-old mildly obese man for dyspnea. Cardiology evaluation 1 year earlier included normal transthoracic and stress echocardiograms. He is referred for CPET.
His peak Vo 2 is low in indexed terms (22.3 mL/kg/min; 74% of predicted) but 90% of predicted in absolute terms (2.8 L/min), re- Normal FIGURE 3. The Ve/Vco 2 slope is elevated in advanced heart failure and other hemodynamically significant cardiopulmonary conditions. Ve/Vo 2 and Ve/Vco LECLERC flecting the contribution of his obesity. His ventilatory threshold is near the lower end of normal (50% of peak Vo 2 ), and all other findings are normal. You conclude his dyspnea is due to deconditioning and obesity.
Case 2: Diastolic dysfunction
You follow a normal-weight 65-year-old woman who has long-standing exertional dyspnea. Evaluation 1 year ago included an echocardiogram showing a normal left ventricular ejection fraction and grade II (moderate) diastolic dysfunction, a normal exercise stress test (details were not provided), normal pulmonary function testing, and high-resolution computed tomography of the chest. She too is referred for CPET.
The findings include mild sinus tachycardia at rest and low peak Vo 2 (23.7 mL/kg/ min; 69% of predicted). The Ve/Vco 2 slope is substantially elevated at 43. Other measures of cardiopulmonary impairment and ventilatory inefficiency such as the end-tidal Pco 2 response, oxygen uptake efficiency slope, and oxygen-pulse relationship (O 2 -pulse, a surrogate for stroke volume) are also abnormal. In clinical context this suggests diastolic dysfunction or unappreciated pulmonary hypertension. You refer her for right heart catheterization, which confirms findings consistent with diastolic dysfunction.
Case 3: Systemic sclerosis
A 64-year-old woman with systemic sclerosis, hypertension, diabetes, and sleep apnea is referred for CPET evaluation of dyspnea. Echocardiography 6 months ago showed a normal left ventricular ejection fraction and moderate diastolic dysfunction.
She undergoes screening spirometry. Results are abnormal and suggest restrictive disease, borderline-low breathing reserve, and low peak Vo 2 (20 mL/kg/min; 71% of predicted). She also has chronotropic incompetence (peak heart rate 105 beats per minute; 67% of predicted). These findings are thought to be manifestations of her systemic sclerosis. You refer her for both pulmonary and electrophysiology consultation.
Case 4: Mitral valve prolapse
A generally healthy 73-year-old woman undergoes echocardiography because of a murmur. Findings reveal mitral valve prolapse and mitral regurgitation, which is difficult to quantify. She is referred for CPET as a noninvasive means of assessing the hemodynamic significance of her mitral regurgitation.
Her overall peak Vo 2 is low (15 mL/kg/ min). The Ve/Vco 2 slope is elevated at 32 (normal < 30), and end-tidal Pco 2 response is also abnormal. The recovery heart rate is also abnormally elevated. Collectively, these findings indicate that her mitral valve regurgitation is hemodynamically significant, and you refer her for mitral valve surgery.
■ CPET'S ROLE IN HEART FAILURE
Over 2 decades ago, the direct measure of peak Vo 2 during exercise was found to be an important prognosticator for patients with advanced heart failure and thus became a conventional measure for stratifying patients most in need of a heart transplant.
14 To this day, a peak Vo 2 of 14 mL/kg/min remains a prognostic threshold-values this low or less carry a poor prognosis.
Additional CPET variables are prognostically useful, both independently and with each other. Many of them reflect the ventilatory and metabolic inefficiencies that result from the extensive central and peripheral pathophysiology seen in heart failure. Oxygen uptake efficiency slope ≤ 1.4 2
Peak Vo 2 ≤ 14 mL/kg/min 2 Score > 15 points: annual mortality rate 12.2%; relative risk > 9 for transplant, left ventricular assist device, or cardiac death. Score < 5 points: annual mortality rate 1.2%. a Maximum heart rate minus heart rate at 1 minute in recovery. b 2 points if on a beta-blocker.
An elevated Ve/Vco 2 slope is a strong predictor of adverse outcomes for patients with heart failure with either reduced or preserved ejection fraction. 18, 19 Other recognized prognostic indicators include [20] [21] [22] [23] : Low end-tidal Pco 2 Exercise oscillatory breathing Low oxygen uptake efficiency slope. All of these are readily provided in the reports of modern CPET systems. Explanations are in Table 1 .
Collectively, these variables are strong predictors of outcomes in heart failure patients in terms of survival, adverse cardiac events, or progression to advanced therapy such as a left ventricular assist device or transplant. A multicenter consortium analyzed CPET results from more than 2,600 systolic heart failure patients and devised a scoring system for predicting outcomes ( Table 3 ). This scoring system is a recommended component of the standard evaluation in patients with advanced heart failure. 24 
■ EXERCISE TEST REPORTING
Currently there is no universal reporting format for CPET. Using a systematic approach such as the one proposed by Guazzi et al 5 can help assure that abnormal values and patterns in all areas will be identified and incorporated in test interpretation. Table 4 lists suggested components of a CPET report and representative examples.
■ OTHER USES OF EXERCISE TESTING
CPET has also been found useful in several other clinical conditions that are beyond the scope of this review. These include pulmonary hypertension, 25 differentiation of pathologic vs physiologic hypertrophy of the left ventricle, 26 preclinical diastolic dysfunction, 27, 28 congenital heart disease in adults, 29 prediction of postoperative complications in bariatric surgery, 30 preoperative evaluation for lung resection and pectus excavatum, 31, 32 hemodynamic impact of mitral regurgitation, 33 and mitochondrial myopathies.
■ COST-EFFECTIVENESS UNKNOWN
The Current Procedural Terminology code for billing for CPET is 94621 (complex pulmonary stress test). The technical fee is $1,605, and the professional fee is $250. The allowable charges vary according to insurer, but under 
Summary statement
The bottom line for referring provider; normal vs abnormal; if abnormal, suggest differential diagnoses; CPET score for heart failure (see Table 3 The cost-effectiveness of CPET has not been studied. As illustrated in the case examples, patients often undergo numerous tests before CPET. While one might infer that CPET could streamline testing and management if done sooner in disease evaluation, this hypothesis has not been adequately studied, and further research is needed to determine if and how doing so will affect overall costs.
■ IMPLICATIONS FOR PRACTICE
Newer hardware and software have made CPET more available to practicing clinicians.
CPET has proven value in evaluating patients with exertional dyspnea. If firstline evaluation has not revealed an obvious cause of a patient's dyspnea, CPET should be considered. This may avoid additional testing or streamline subsequent evaluation and management. CPET also has an established role in risk stratification of those with heart failure.
The clinical application of CPET continues to evolve. Future research will continue to refine its diagnostic and prognostic abilities in a variety of diseases. Most major hospitals and medical centers have CPET capabilities, and interested practitioners should seek out those experienced in test interpretation to increase personal familiarity and to foster appropriate patient referrals.
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